 prevent bacteri infect neutropen patient hematolog malign random multicent trial norfloxacin ciprofloxacin gimema infect program gruppo italiano malatti ematologich malign dell'adulto object efficaci norfloxacin ciprofloxacin bacteri infect neutropen patient design random trial set twenty-on hematolog unit tertiari care univers hospit patient eight consecut afebril adult patient hematolog malign bone marrow transplant chemotherapy-induc neutropenia neutrophil count last day intervent patient hour mg ciprofloxacin measur efficaci analysi patient norfloxacin ciprofloxacin main result patient ciprofloxacin fever neutropenia antibiot norfloxacin patient ciprofloxacin rate infect infect gram-neg bacilli interv first febril episod patient ciprofloxacin day rate infect fever unknown origin mortal complianc toler similar group patient day sever neutropenia day antifung prophylaxi ciprofloxacin therapi conclus ciprofloxacin develop infect neutropen patient hematolog malign